CliffBio
small molecule

BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE

ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Loss of exclusivity—loss of exclusivity
CompanyHIKMA INTERNATIONAL PHARMACEUTICALS LLC

Drug detail

Brand nameBUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Active ingredientACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Strength325MG;50MG;40MG;30MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2001
Marketing statusDISCN

More from HIKMA INTERNATIONAL PHARMACEUTICALS LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE patent cliff — loss of exclusivity — | CliffBio